Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,431 people get ONTY articles and Market Currents by email alert.
Get email alerts on ONTY »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
PR Newswire (May 9, 2013)
-
PR Newswire (May 2, 2013)
-
-
PR Newswire (Mar 29, 2013)
-
PR Newswire (Mar 14, 2013)
-
PR Newswire (Mar 7, 2013)
-
-
PR Newswire (Feb 27, 2013)
-
-
-
-
-
Stock Watch Wednesday, 12 DecemberVFC's Stock House • Wed, Dec 12, 2012
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
Oncothyreon: Consider Buying Dips but Beware of VolatilityVFC's Stock House • Wed, Jul 27, 2011
-
-
-
-
-
-
Oncothyreon's Run Indicates the Stock Is Rising Above the RadarVFC's Stock House • Wed, May 18, 2011
-
-
-
-
-
-
-
-
Stock Watch Wednesday, 12 DecemberVFC's Stock House • Wed, Dec 12, 2012
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Weekly Stock Watch, Week Of July 1VFC's Stock House • Mon, Jul 2, 2012
-
PR Newswire (May 9, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (Mar 29, 2013)
-
PR Newswire (Mar 14, 2013)
-
PR Newswire (Mar 7, 2013)
-
PR Newswire (Feb 27, 2013)
-
at MarketWatch.com (Dec 19, 2012)
-
PR Newswire (Nov 7, 2012)
-
PR Newswire (Nov 7, 2012)
-
PR Newswire (Oct 31, 2012)
-
PR Newswire (Sep 5, 2012)
-
PR Newswire (Aug 29, 2012)
-
PR Newswire (Aug 9, 2012)
-
PR Newswire (Aug 8, 2012)
-
PR Newswire (Aug 8, 2012)
-
PR Newswire (Jul 24, 2012)
-
PR Newswire (Jul 5, 2012)
-
PR Newswire (Jun 21, 2012)
ONTY vs. ETF Alternatives
Company Description
Oncothyreon, Inc. is a clinical-stage biopharmaceutical company focused primarily on the development of therapeutic products for the treatment of cancer. Our goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives... More
-
Jonathan Spencer
This $ONTY also got upgraded right? We might have some info for you on $ONTY later for now, Enjoy $INHX - View all 0 replies
-
- View all 0 replies
-
Michael Kudrna
Reduced $ONTY on this bounce at 7.72 average and may look to reload after the share offering price is determined $$ - View all 0 replies
-
Michael Kudrna
$ONTY starting to perk up again, light volume move though like most stocks this week $$ - View all 0 replies
-
Michael Kudrna
Watch $ONTY on a breakout today, early strength but volume nothing to get excited about yet $$ - View all 0 replies
-
Michael Kudrna
Added to tracking position in $ONTY at $7.75 as it hovers around trendline support and above the 20-day SMA $$ - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Timeless Wealth
$DNDN on the rebound as are other immunotherapy biotechs $IMUC (+5.71%), $CLDX (+4.58%), $ONTY (+3.59%) - View all 0 replies
-
- View all 0 replies
LATEST REPLIES